{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T07:58:54Z","timestamp":1773215934603,"version":"3.50.1"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"C","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction and importance:<\/jats:title>\n                    <jats:p>Fibrodysplasia Ossificans Progressiva (FOP) is an exceptionally rare genetic disorder characterized by progressive heterotopic ossification of soft tissues and congenital skeletal anomalies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation:<\/jats:title>\n                    <jats:p>This report presents the case of a 12-year-old boy with hallmark features of FOP alongside rare congenital abnormalities, including bilateral microdactyly and thumb adhesion to the palms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical discussion:<\/jats:title>\n                    <jats:p>Initially misdiagnosed as muscular dystrophy, the patient's condition deteriorated under inappropriate management. Genetic testing confirmed a heterozygous mutation (c.617G &gt; A; p.R206H) in the ACVR1 gene.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This case highlights the importance of early recognition of atypical congenital malformations in FOP, the risks of invasive interventions, and the necessity for genetic confirmation to prevent iatrogenic harm. A comprehensive review of the literature is also provided.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Highlights<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1016\/j.ijscr.2025.111652","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:18:18Z","timestamp":1752610698000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Atypical Fibrodysplasia Ossificans Progressiva in a child: A case report"],"prefix":"10.1097","volume":"133","author":[{"given":"Abdullah","family":"Noufal","sequence":"first","affiliation":[{"name":"ASPU (AlSham Private University), Damascus, Syria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaman","family":"Alsharef","sequence":"additional","affiliation":[{"name":"Damascus University, Damascus, Syria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aya Abou","family":"Alainein","sequence":"additional","affiliation":[{"name":"Damascus University, Damascus, Syria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Adi","sequence":"additional","affiliation":[{"name":"Damascus University, Damascus, Syria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Jumaa","sequence":"additional","affiliation":[{"name":"Damascus University, Damascus, Syria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah","family":"Alfandi","sequence":"additional","affiliation":[{"name":"ASPU (AlSham Private University), Damascus, Syria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"5","key":"R1-142-20260310","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/ng1783","article-title":"A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva","volume":"38","author":"Shore","year":"2006","journal-title":"Nat. Genet"},{"key":"R2-142-20260310","first-page":"1","article-title":"The medical management of fibrodysplasia ossificans progressiva: current treatment considerations","volume":"1","author":"Kaplan","year":"2019","journal-title":"Clin Proc Int Clin Council FOP"},{"issue":"1","key":"R4-142-20260310","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s13023-017-0674-5","article-title":"Prevalence of fibrodysplasia ossificans progressiva (FOP) in France: an estimate based on a record linkage of national databases","volume":"12","author":"Baujat","year":"2017","journal-title":"Orphanet J. Rare Dis"},{"issue":"Suppl. 2","key":"R5-142-20260310","first-page":"437","article-title":"Fibrodysplasia ossificans progressiva: diagnosis, management, and therapeutic horizons","volume":"10","author":"Pignolo","year":"2013","journal-title":"Pediatr. Endocrinol. Rev"},{"issue":"1","key":"R6-142-20260310","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.berh.2007.11.007","article-title":"Fibrodysplasia ossificans progressiva","volume":"22","author":"Kaplan","year":"2008","journal-title":"Best Pract. Res. Clin. Rheumatol"},{"issue":"5","key":"R8-142-20260310","doi-asserted-by":"crossref","first-page":"e654","DOI":"10.1542\/peds.2005-0469","article-title":"Iatrogenic harm in fibrodysplasia ossificans progressiva","volume":"116","author":"Kitterman","year":"2005","journal-title":"Pediatrics"},{"key":"R9-142-20260310","article-title":"Revised surgical CAse REport (SCARE) guideline: an update for the age of artificial intelligence","volume":"10","author":"Kerwan","year":"2025","journal-title":"Premier Journal of Science"},{"issue":"3","key":"R10-142-20260310","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/humu.20868","article-title":"Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the ACVR1 gene","volume":"30","author":"Kaplan","year":"2009","journal-title":"Hum. Mutat"},{"issue":"6","key":"R11-142-20260310","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.chest.2017.12.018","article-title":"The challenge of rare diseases","volume":"153","author":"Stoller","year":"2018","journal-title":"Chest"},{"issue":"1","key":"R14-142-20260310","first-page":"456","article-title":"Whole-body MRI in FOP","volume":"30","author":"Murchison","year":"2020","journal-title":"Eur. Radiol"},{"key":"R15-142-20260310","article-title":"Saracatinib as targeted therapy in FOP","volume":"160","author":"Haupt","year":"2022","journal-title":"Bone"},{"issue":"1","key":"R16-142-20260310","first-page":"12","article-title":"Rapamycin effects in murine model of FOP","volume":"18","author":"Brown","year":"2023","journal-title":"Orphanet J. Rare Dis"},{"issue":"2","key":"R17-142-20260310","first-page":"121","article-title":"Clinical variability in atypical FOP","volume":"104","author":"Song","year":"2023","journal-title":"Clin. Genet"},{"issue":"6","key":"R18-142-20260310","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1359\/jbmr.091110","article-title":"ALK2 R206H mutation linked to fibrodysplasia ossificans progressiva confers constitutive activity to the BMP type I receptor and sensitizes mesenchymal cells to BMP-induced osteoblast differentiation and bone formation","volume":"25","author":"van Dinther","year":"2010","journal-title":"J. Bone Miner. Res"},{"issue":"50","key":"R19-142-20260310","doi-asserted-by":"crossref","first-page":"15438","DOI":"10.1073\/pnas.1510540112","article-title":"Neofunction of ACVR1 in fibrodysplasia ossificans progressiva","volume":"112","author":"Hino","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"R20-142-20260310","doi-asserted-by":"crossref","DOI":"10.1002\/jbmr.3235","article-title":"The expansion of heterotopic bone in fibrodysplasia ossificans progressiva is activin A-dependent","author":"Upadhyay","year":"2017","journal-title":"J. Bone Miner. Res"},{"key":"R21-142-20260310","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.bone.2017.06.011","article-title":"The obligatory role of Activin A in the formation of heterotopic bone in fibrodysplasia ossificans progressiva","volume":"109","author":"Alessi Wolken","year":"2018","journal-title":"Bone"},{"issue":"6","key":"R22-142-20260310","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/ard.41.6.646-c","article-title":"Histocompatibility antigens in patients with ectopic ossification due to fibrodysplasia ossificans progressiva","volume":"41","author":"Connor","year":"1982","journal-title":"Ann. Rheum. Dis"},{"key":"R23-142-20260310","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1517\/21678707.2013.825208","article-title":"From mysteries to medicines: drug development for fibrodysplasia ossificans progressive","volume":"1","author":"Kaplan","year":"2013","journal-title":"Expert Opin. Orphan Drugs"}],"container-title":["International Journal of Surgery Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210261225008387?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210261225008387?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/10.1016\/j.ijscr.2025.111652","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T10:06:36Z","timestamp":1773137196000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1016\/j.ijscr.2025.111652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":19,"journal-issue":{"issue":"C","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1016\/j.ijscr.2025.111652","relation":{},"ISSN":["2210-2612"],"issn-type":[{"value":"2210-2612","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"2025-05-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-09","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}